ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 137 filers reported holding ARGENX SE in Q2 2019. The put-call ratio across all filers is 2.14 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $4,985,535 | +166.5% | 13,105 | +244.4% | 0.00% | +100.0% |
Q3 2023 | $1,870,652 | +16.1% | 3,805 | -8.0% | 0.00% | 0.0% |
Q2 2023 | $1,611,534 | +95313.5% | 4,135 | -8.8% | 0.00% | 0.0% |
Q1 2023 | $1,689 | -1.7% | 4,534 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $1,718 | -100.0% | 4,534 | -83.7% | 0.00% | -75.0% |
Q3 2022 | $9,798,000 | +483.9% | 27,750 | +526.7% | 0.00% | +300.0% |
Q2 2022 | $1,678,000 | +44.5% | 4,428 | -14.1% | 0.00% | – |
Q2 2020 | $1,161,000 | +1.0% | 5,155 | -40.9% | 0.00% | -100.0% |
Q1 2020 | $1,149,000 | -31.6% | 8,721 | -16.7% | 0.00% | 0.0% |
Q4 2019 | $1,680,000 | +32.1% | 10,469 | -6.2% | 0.00% | 0.0% |
Q3 2019 | $1,272,000 | -12.6% | 11,165 | +8.5% | 0.00% | 0.0% |
Q2 2019 | $1,456,000 | +278.2% | 10,286 | +233.6% | 0.00% | -50.0% |
Q1 2019 | $385,000 | – | 3,083 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 285,198 | $106,259,071 | 29.06% |
Avoro Capital Advisors LLC | 1,287,500 | $479,696,750 | 7.11% |
Paradigm Biocapital Advisors LP | 181,172 | $67,501,064 | 6.40% |
DCF Advisers, LLC | 25,700 | $9,575,310 | 5.86% |
Artia Global Partners LP | 36,404 | $13,563,402 | 5.01% |
Bellevue Group AG | 886,928 | $330,451,634 | 4.80% |
Fairmount Funds Management LLC | 73,526 | $27,394,317 | 4.71% |
Eagle Health Investments LP | 64,400 | $23,994,152 | 4.67% |
Decheng Capital Management III (Cayman), LLC | 27,429 | $10,219,497 | 4.12% |
RTW INVESTMENTS, LP | 482,195 | $179,656,213 | 3.74% |